Unknown

Dataset Information

0

Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.


ABSTRACT: The objective of this study was to evaluate whether orally administered anti-infectives increase the risk of severe hypoglycemia in users of glipizide or glyburide. We performed two case-control studies and two case-crossover studies using US Medicaid data. All the anti-infectives examined were associated with an elevated risk of severe hypoglycemia. Using cephalexin as the reference category, in glipizide users, statistically significant associations were found with co-trimoxazole (odds ratio (OR) = 3.14; 95% confidence interval (CI): 1.83-5.37); clarithromycin (OR = 2.90; 95% CI: 1.69-4.98); fluconazole (OR = 2.53; 95% CI: 1.23-5.23); and levofloxacin (OR = 2.09; 95% CI: 1.35-3.25). In glyburide users, with cephalexin as the reference, statistically significant associations were found with clarithromycin (OR = 5.02; 95% CI: 3.35-7.54); levofloxacin (OR = 2.83; 95% CI: 1.73-4.62); co-trimoxazole (OR = 2.68; 95% CI: 1.59-4.52); fluconazole (OR = 2.20; 95% CI: 1.04-4.68); and ciprofloxacin (OR = 2.08; 95% CI: 1.23-3.52). In conclusion, exposure to all studied anti-infective agents were associated with subsequent severe hypoglycemia. Using cephalexin as the reference, drug-drug interactions were evident with ciprofloxacin (in glyburide users only), clarithromycin, co-trimoxazole, fluconazole, and levofloxacin.

SUBMITTER: Schelleman H 

PROVIDER: S-EPMC2908202 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.

Schelleman H H   Bilker W B WB   Brensinger C M CM   Wan F F   Hennessy S S  

Clinical pharmacology and therapeutics 20100630 2


The objective of this study was to evaluate whether orally administered anti-infectives increase the risk of severe hypoglycemia in users of glipizide or glyburide. We performed two case-control studies and two case-crossover studies using US Medicaid data. All the anti-infectives examined were associated with an elevated risk of severe hypoglycemia. Using cephalexin as the reference category, in glipizide users, statistically significant associations were found with co-trimoxazole (odds ratio (  ...[more]

Similar Datasets

| S-EPMC6554646 | biostudies-other
| S-EPMC4890073 | biostudies-literature
| S-EPMC7205195 | biostudies-literature
| S-EPMC4828264 | biostudies-other
| S-EPMC4408247 | biostudies-literature
| S-EPMC4199284 | biostudies-literature
| S-EPMC5588407 | biostudies-literature
| S-EPMC7275423 | biostudies-literature
| S-EPMC7114281 | biostudies-literature
| S-EPMC3857168 | biostudies-literature